Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global Winged IV Needles market is projected to grow from US$ 1626 million in 2025 to US$ 2218 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Winged IV needles are medical devices used for intravenous injection or blood collection. They are designed with a wing-shaped structure to facilitate medical staff to hold and operate. The needle tube is usually thinner and suitable for short-term or single use to reduce irritation and damage to blood vessels. The winged design can provide better stability and control and is often used for venipuncture in children, the elderly or patients with thin blood vessels.
Winged IV Needles Market Size(US$)
M= millions and B=billions

From a downstream perspective, Hospital accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Winged IV Needles leading manufacturers (including B Braun, Terumo, BD, NIPRO Medical, Smiths Medical, Medtronic, Hindustan Syringes & Medical Devices(HMD), Sungwon Medical, KDL, WEGO Group, etc.), dominate supply; the top five capture approximately % of global revenue, with B Braun leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Winged IV Needles market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
Report Metric
Details
Report Title
Global Winged IV Needles Market Outlook, In‑Depth Analysis & Forecast to 2032
Forecasted Market Size in 2032
US$ 2218 million
CAGR(2026-2032)
4.6%
Market Size Available for Years
2026-2032
Global Winged IV Needles Companies Covered
B Braun
Terumo
BD
NIPRO Medical
Smiths Medical
Medtronic
Hindustan Syringes & Medical Devices(HMD)
Sungwon Medical
KDL
WEGO Group
TuoRen Group
Biop Medical
Sinomed
Global Winged IV Needles Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Winged IV Needles Market, Segment by Type
Short Catheter (10-20mm)
Long Catheter (25-50mm)
Global Winged IV Needles Market, Segment by Application
Hospital
Clinic
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Defines the Winged IV Needles study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Table of Contents
1 Study Coverage
1.1 Introduction to Winged IV Needles: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Winged IV Needles Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Short Catheter (10-20mm)
1.2.3 Long Catheter (25-50mm)
1.3 Market Segmentation by Application
1.3.1 Global Winged IV Needles Market Size by Application, 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Winged IV Needles Revenue Estimates and Forecasts (2021-2032)
2.2 Global Winged IV Needles Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Winged IV Needles Sales Estimates and Forecasts (2021-2032)
2.4 Global Winged IV Needles Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)
3 Competitive Landscape
3.1 Global Winged IV Needles Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Winged IV Needles Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Short Catheter (10-20mm): Market Share by Key Manufacturers
3.5.2 Long Catheter (25-50mm): Market Share by Key Manufacturers
3.6 Global Winged IV Needles Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Product Segmentation
4.1 Global Winged IV Needles Sales Performance by Type
4.1.1 Global Winged IV Needles Sales Volume by Type (2021-2032)
4.1.2 Global Winged IV Needles Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Product Technology Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Downstream Applications and Customers
5.1 Global Winged IV Needles Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Winged IV Needles Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Winged IV Needles Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Winged IV Needles Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Winged IV Needles Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Winged IV Needles Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Winged IV Needles Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Winged IV Needles Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Winged IV Needles Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Winged IV Needles Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Winged IV Needles Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Winged IV Needles Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa
11 Corporate Profile
11.1 B Braun
11.1.1 B Braun Corporation Information
11.1.2 B Braun Business Overview
11.1.3 B Braun Winged IV Needles Product Models, Descriptions and Specifications
11.1.4 B Braun Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 B Braun Winged IV Needles Sales by Product in 2025
11.1.6 B Braun Winged IV Needles Sales by Application in 2025
11.1.7 B Braun Winged IV Needles Sales by Geographic Area in 2025
11.1.8 B Braun Winged IV Needles SWOT Analysis
11.1.9 B Braun Recent Developments
11.2 Terumo
11.2.1 Terumo Corporation Information
11.2.2 Terumo Business Overview
11.2.3 Terumo Winged IV Needles Product Models, Descriptions and Specifications
11.2.4 Terumo Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Terumo Winged IV Needles Sales by Product in 2025
11.2.6 Terumo Winged IV Needles Sales by Application in 2025
11.2.7 Terumo Winged IV Needles Sales by Geographic Area in 2025
11.2.8 Terumo Winged IV Needles SWOT Analysis
11.2.9 Terumo Recent Developments
11.3 BD
11.3.1 BD Corporation Information
11.3.2 BD Business Overview
11.3.3 BD Winged IV Needles Product Models, Descriptions and Specifications
11.3.4 BD Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 BD Winged IV Needles Sales by Product in 2025
11.3.6 BD Winged IV Needles Sales by Application in 2025
11.3.7 BD Winged IV Needles Sales by Geographic Area in 2025
11.3.8 BD Winged IV Needles SWOT Analysis
11.3.9 BD Recent Developments
11.4 NIPRO Medical
11.4.1 NIPRO Medical Corporation Information
11.4.2 NIPRO Medical Business Overview
11.4.3 NIPRO Medical Winged IV Needles Product Models, Descriptions and Specifications
11.4.4 NIPRO Medical Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 NIPRO Medical Winged IV Needles Sales by Product in 2025
11.4.6 NIPRO Medical Winged IV Needles Sales by Application in 2025
11.4.7 NIPRO Medical Winged IV Needles Sales by Geographic Area in 2025
11.4.8 NIPRO Medical Winged IV Needles SWOT Analysis
11.4.9 NIPRO Medical Recent Developments
11.5 Smiths Medical
11.5.1 Smiths Medical Corporation Information
11.5.2 Smiths Medical Business Overview
11.5.3 Smiths Medical Winged IV Needles Product Models, Descriptions and Specifications
11.5.4 Smiths Medical Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Smiths Medical Winged IV Needles Sales by Product in 2025
11.5.6 Smiths Medical Winged IV Needles Sales by Application in 2025
11.5.7 Smiths Medical Winged IV Needles Sales by Geographic Area in 2025
11.5.8 Smiths Medical Winged IV Needles SWOT Analysis
11.5.9 Smiths Medical Recent Developments
11.6 Medtronic
11.6.1 Medtronic Corporation Information
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Winged IV Needles Product Models, Descriptions and Specifications
11.6.4 Medtronic Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 Medtronic Recent Developments
11.7 Hindustan Syringes & Medical Devices(HMD)
11.7.1 Hindustan Syringes & Medical Devices(HMD) Corporation Information
11.7.2 Hindustan Syringes & Medical Devices(HMD) Business Overview
11.7.3 Hindustan Syringes & Medical Devices(HMD) Winged IV Needles Product Models, Descriptions and Specifications
11.7.4 Hindustan Syringes & Medical Devices(HMD) Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Hindustan Syringes & Medical Devices(HMD) Recent Developments
11.8 Sungwon Medical
11.8.1 Sungwon Medical Corporation Information
11.8.2 Sungwon Medical Business Overview
11.8.3 Sungwon Medical Winged IV Needles Product Models, Descriptions and Specifications
11.8.4 Sungwon Medical Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Sungwon Medical Recent Developments
11.9 KDL
11.9.1 KDL Corporation Information
11.9.2 KDL Business Overview
11.9.3 KDL Winged IV Needles Product Models, Descriptions and Specifications
11.9.4 KDL Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 KDL Recent Developments
11.10 WEGO Group
11.10.1 WEGO Group Corporation Information
11.10.2 WEGO Group Business Overview
11.10.3 WEGO Group Winged IV Needles Product Models, Descriptions and Specifications
11.10.4 WEGO Group Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 WEGO Group Recent Developments
11.11 TuoRen Group
11.11.1 TuoRen Group Corporation Information
11.11.2 TuoRen Group Business Overview
11.11.3 TuoRen Group Winged IV Needles Product Models, Descriptions and Specifications
11.11.4 TuoRen Group Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 TuoRen Group Recent Developments
11.12 Biop Medical
11.12.1 Biop Medical Corporation Information
11.12.2 Biop Medical Business Overview
11.12.3 Biop Medical Winged IV Needles Product Models, Descriptions and Specifications
11.12.4 Biop Medical Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Biop Medical Recent Developments
11.13 Sinomed
11.13.1 Sinomed Corporation Information
11.13.2 Sinomed Business Overview
11.13.3 Sinomed Winged IV Needles Product Models, Descriptions and Specifications
11.13.4 Sinomed Winged IV Needles Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Sinomed Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Winged IV Needles Industry Chain
12.2 Winged IV Needles Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Winged IV Needles Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Winged IV Needles Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Winged IV Needles Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs
14 Key Findings in the Global Winged IV Needles Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
Table of Figures
List of Tables
Table 1. Global Winged IV Needles Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Winged IV Needles Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Winged IV Needles Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Winged IV Needles Revenue by Region (US$ Million), 2021-2026
Table 5. Global Winged IV Needles Revenue by Region (US$ Million), 2027-2032
Table 6. Global Winged IV Needles Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 7. Global Winged IV Needles Sales by Region (K Units), 2021-2026
Table 8. Global Winged IV Needles Sales by Region (K Units), 2027-2032
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 10. Global Winged IV Needles Sales by Manufacturers (K Units), 2021-2026
Table 11. Global Winged IV Needles Sales Share by Manufacturers (2021-2026)
Table 12. Global Winged IV Needles Revenue by Manufacturers (US$ Million), 2021-2026
Table 13. Global Winged IV Needles Revenue-Based Market Share by Manufacturers (2021-2026)
Table 14. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 15. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Winged IV Needles Revenue, 2025
Table 16. Global Winged IV Needles Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 17. Global Winged IV Needles Average Selling Price (ASP) by Manufacturers (US$/K Units), 2021-2026
Table 18. Key Manufacturers Winged IV Needles Manufacturing Base and Headquarters
Table 19. Global Winged IV Needles Market Concentration Ratio (CR5)
Table 20. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Winged IV Needles Sales Volume by Type (K Units), 2021-2026
Table 23. Global Winged IV Needles Sales Volume by Type (K Units), 2027-2032
Table 24. Global Winged IV Needles Revenue by Type (US$ Million), 2021-2026
Table 25. Global Winged IV Needles Revenue by Type (US$ Million), 2027-2032
Table 26. Technical Specifications by Key Product Type
Table 27. Global Winged IV Needles Sales by Application (K Units), 2021-2026
Table 28. Global Winged IV Needles Sales by Application (K Units), 2027-2032
Table 29. Winged IV Needles High-Growth Sectors Demand CAGR (2026-2032)
Table 30. Global Winged IV Needles Revenue by Application (US$ Million), 2021-2026
Table 31. Global Winged IV Needles Revenue by Application (US$ Million), 2027-2032
Table 32. Top Customers by Region
Table 33. Top Customers by Application
Table 34. North America Winged IV Needles Growth Accelerators and Market Barriers
Table 35. North America Winged IV Needles Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 36. North America Winged IV Needles Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 37. Europe Winged IV Needles Growth Accelerators and Market Barriers
Table 38. Europe Winged IV Needles Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 39. Europe Winged IV Needles Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 40. Asia-Pacific Winged IV Needles Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Asia-Pacific Winged IV Needles Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 42. Asia-Pacific Winged IV Needles Growth Accelerators and Market Barriers
Table 43. Southeast Asia Winged IV Needles Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 44. Central and South America Winged IV Needles Investment Opportunities and Key Challenges
Table 45. Central and South America Winged IV Needles Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 46. Middle East and Africa Winged IV Needles Investment Opportunities and Key Challenges
Table 47. Middle East and Africa Winged IV Needles Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 48. B Braun Corporation Information
Table 49. B Braun Description and Major Businesses
Table 50. B Braun Product Models, Descriptions and Specifications
Table 51. B Braun Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 52. B Braun Sales Value Proportion by Product in 2025
Table 53. B Braun Sales Value Proportion by Application in 2025
Table 54. B Braun Sales Value Proportion by Geographic Area in 2025
Table 55. B Braun Winged IV Needles SWOT Analysis
Table 56. B Braun Recent Developments
Table 57. Terumo Corporation Information
Table 58. Terumo Description and Major Businesses
Table 59. Terumo Product Models, Descriptions and Specifications
Table 60. Terumo Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 61. Terumo Sales Value Proportion by Product in 2025
Table 62. Terumo Sales Value Proportion by Application in 2025
Table 63. Terumo Sales Value Proportion by Geographic Area in 2025
Table 64. Terumo Winged IV Needles SWOT Analysis
Table 65. Terumo Recent Developments
Table 66. BD Corporation Information
Table 67. BD Description and Major Businesses
Table 68. BD Product Models, Descriptions and Specifications
Table 69. BD Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 70. BD Sales Value Proportion by Product in 2025
Table 71. BD Sales Value Proportion by Application in 2025
Table 72. BD Sales Value Proportion by Geographic Area in 2025
Table 73. BD Winged IV Needles SWOT Analysis
Table 74. BD Recent Developments
Table 75. NIPRO Medical Corporation Information
Table 76. NIPRO Medical Description and Major Businesses
Table 77. NIPRO Medical Product Models, Descriptions and Specifications
Table 78. NIPRO Medical Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 79. NIPRO Medical Sales Value Proportion by Product in 2025
Table 80. NIPRO Medical Sales Value Proportion by Application in 2025
Table 81. NIPRO Medical Sales Value Proportion by Geographic Area in 2025
Table 82. NIPRO Medical Winged IV Needles SWOT Analysis
Table 83. NIPRO Medical Recent Developments
Table 84. Smiths Medical Corporation Information
Table 85. Smiths Medical Description and Major Businesses
Table 86. Smiths Medical Product Models, Descriptions and Specifications
Table 87. Smiths Medical Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 88. Smiths Medical Sales Value Proportion by Product in 2025
Table 89. Smiths Medical Sales Value Proportion by Application in 2025
Table 90. Smiths Medical Sales Value Proportion by Geographic Area in 2025
Table 91. Smiths Medical Winged IV Needles SWOT Analysis
Table 92. Smiths Medical Recent Developments
Table 93. Medtronic Corporation Information
Table 94. Medtronic Description and Major Businesses
Table 95. Medtronic Product Models, Descriptions and Specifications
Table 96. Medtronic Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 97. Medtronic Recent Developments
Table 98. Hindustan Syringes & Medical Devices(HMD) Corporation Information
Table 99. Hindustan Syringes & Medical Devices(HMD) Description and Major Businesses
Table 100. Hindustan Syringes & Medical Devices(HMD) Product Models, Descriptions and Specifications
Table 101. Hindustan Syringes & Medical Devices(HMD) Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 102. Hindustan Syringes & Medical Devices(HMD) Recent Developments
Table 103. Sungwon Medical Corporation Information
Table 104. Sungwon Medical Description and Major Businesses
Table 105. Sungwon Medical Product Models, Descriptions and Specifications
Table 106. Sungwon Medical Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 107. Sungwon Medical Recent Developments
Table 108. KDL Corporation Information
Table 109. KDL Description and Major Businesses
Table 110. KDL Product Models, Descriptions and Specifications
Table 111. KDL Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 112. KDL Recent Developments
Table 113. WEGO Group Corporation Information
Table 114. WEGO Group Description and Major Businesses
Table 115. WEGO Group Product Models, Descriptions and Specifications
Table 116. WEGO Group Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 117. WEGO Group Recent Developments
Table 118. TuoRen Group Corporation Information
Table 119. TuoRen Group Description and Major Businesses
Table 120. TuoRen Group Product Models, Descriptions and Specifications
Table 121. TuoRen Group Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 122. TuoRen Group Recent Developments
Table 123. Biop Medical Corporation Information
Table 124. Biop Medical Description and Major Businesses
Table 125. Biop Medical Product Models, Descriptions and Specifications
Table 126. Biop Medical Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 127. Biop Medical Recent Developments
Table 128. Sinomed Corporation Information
Table 129. Sinomed Description and Major Businesses
Table 130. Sinomed Product Models, Descriptions and Specifications
Table 131. Sinomed Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2021-2026)
Table 132. Sinomed Recent Developments
Table 133. Key Raw Materials Distribution
Table 134. Raw Materials Key Suppliers
Table 135. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 136. Milestones in Production Technology Evolution
Table 137. Distributors List
Table 138. Market Trends and Market Evolution
Table 139. Market Drivers and Opportunities
Table 140. Market Challenges, Risks, and Restraints
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Winged IV Needles Product Picture
Figure 2. Global Winged IV Needles Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Short Catheter (10-20mm) Product Picture
Figure 4. Long Catheter (25-50mm) Product Picture
Figure 5. Global Winged IV Needles Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Winged IV Needles Report Years Considered
Figure 9. Global Winged IV Needles Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 10. Global Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 11. Global Winged IV Needles Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 12. Global Winged IV Needles Revenue-Based Market Share by Region (2021-2032)
Figure 13. Global Winged IV Needles Sales (K Units), 2021-2032
Figure 14. Global Winged IV Needles Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 15. Global Winged IV Needles Sales Market Share by Region (2021-2032)
Figure 16. Top 5 and Top 10 Manufacturers Winged IV Needles Sales Volume Market Share in 2025
Figure 17. Global Winged IV Needles Revenue-Based Market Share Ranking (2025)
Figure 18. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 19. Short Catheter (10-20mm) Revenue-Based Market Share by Manufacturer in 2025
Figure 20. Long Catheter (25-50mm) Revenue-Based Market Share by Manufacturer in 2025
Figure 21. Global Winged IV Needles Sales Volume-Based Market Share by Type (2021-2032)
Figure 22. Global Winged IV Needles Revenue-Based Market Share by Type (2021-2032)
Figure 23. Global Winged IV Needles ASP by Type (US$/K Units), 2021-2032
Figure 24. Global Winged IV Needles Revenue-Based Market Share (2021-2032)
Figure 25. Global Winged IV Needles Sales Market Share by Application (2021-2032)
Figure 26. Global Winged IV Needles Revenue-Based Market Share by Application (2021-2032)
Figure 27. Global Winged IV Needles ASP by Application (US$/K Units), 2021-2032
Figure 28. North America Winged IV Needles Sales YoY (K Units), 2021-2032
Figure 29. North America Winged IV Needles Revenue YoY (US$ Million), 2021-2032
Figure 30. North America Top 5 Manufacturers Winged IV Needles Sales Revenue (US$ Million) in 2025
Figure 31. North America Winged IV Needles Sales Volume (K Units) by Application (2021-2032)
Figure 32. North America Winged IV Needles Sales Revenue (US$ Million) by Application (2021-2032)
Figure 33. US Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 34. Canada Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 35. Mexico Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 36. Europe Winged IV Needles Sales YoY (K Units), 2021-2032
Figure 37. Europe Winged IV Needles Revenue YoY (US$ Million), 2021-2032
Figure 38. Europe Top 5 Manufacturers Winged IV Needles Sales Revenue (US$ Million) in 2025
Figure 39. Europe Winged IV Needles Sales Volume (K Units) by Application (2021-2032)
Figure 40. Europe Winged IV Needles Sales Revenue (US$ Million) by Application (2021-2032)
Figure 41. Germany Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 42. France Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 43. U.K. Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 44. Italy Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 45. Russia Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 46. Asia-Pacific Winged IV Needles Sales YoY (K Units), 2021-2032
Figure 47. Asia-Pacific Winged IV Needles Revenue YoY (US$ Million), 2021-2032
Figure 48. Asia-Pacific Top 8 Manufacturers Winged IV Needles Sales Revenue (US$ Million) in 2025
Figure 49. Asia-Pacific Winged IV Needles Sales Volume (K Units) by Application (2021-2032)
Figure 50. Asia-Pacific Winged IV Needles Sales Revenue (US$ Million) by Application (2021-2032)
Figure 51. Indonesia Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 52. Japan Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 53. South Korea Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 54. China Taiwan Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 55. India Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 56. Central and South America Winged IV Needles Sales YoY (K Units), 2021-2032
Figure 57. Central and South America Winged IV Needles Revenue YoY (US$ Million), 2021-2032
Figure 58. Central and South America Top 5 Manufacturers Winged IV Needles Sales Revenue (US$ Million) in 2025
Figure 59. Central and South America Winged IV Needles Sales Volume (K Units) by Application (2021-2032)
Figure 60. Central and South America Winged IV Needles Sales Revenue (US$ Million) by Application (2021-2032)
Figure 61. Brazil Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 62. Argentina Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 63. Middle East, and Africa Winged IV Needles Sales YoY (K Units), 2021-2032
Figure 64. Middle East and Africa Winged IV Needles Revenue YoY (US$ Million), 2021-2032
Figure 65. Middle East and Africa Top 5 Manufacturers Winged IV Needles Sales Revenue (US$ Million) in 2025
Figure 66. Middle East and Africa Winged IV Needles Sales Volume (K Units) by Application (2021-2032)
Figure 67. Middle East and Africa Winged IV Needles Sales Revenue (US$ Million) by Application (2021-2032)
Figure 68. GCC Countries Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 69. Turkey Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 70. Egypt Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 71. South Africa Winged IV Needles Revenue (US$ Million), 2021-2032
Figure 72. Winged IV Needles Industry Chain Mapping
Figure 73. Regional Winged IV Needles Manufacturing Base Distribution (%)
Figure 74. Global Winged IV Needles Production Market Share by Region (2021-2032)
Figure 75. Winged IV Needles Production Process
Figure 76. Regional Winged IV Needles Production Cost Structure
Figure 77. Channels of Distribution (Direct Vs Distribution)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives InterviewedDescription
The global Winged IV Needles market is projected to grow from US$ 1626 million in 2025 to US$ 2218 million by 2032, at a CAGR of 4.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Winged IV needles are medical devices used for intravenous injection or blood collection. They are designed with a wing-shaped structure to facilitate medical staff to hold and operate. The needle tube is usually thinner and suitable for short-term or single use to reduce irritation and damage to blood vessels. The winged design can provide better stability and control and is often used for venipuncture in children, the elderly or patients with thin blood vessels.
From a downstream perspective, Hospital accounted for % of 2025 revenue, surging to US$ million by 2032 (CAGR: % from 2026–2032).
Winged IV Needles leading manufacturers (including B Braun, Terumo, BD, NIPRO Medical, Smiths Medical, Medtronic, Hindustan Syringes & Medical Devices(HMD), Sungwon Medical, KDL, WEGO Group, etc.), dominate supply; the top five capture approximately % of global revenue, with B Braun leading 2025 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2025 to a forecast US$ million by 2032 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2025, % share rising to % by 2032), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2032 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Winged IV Needles market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
Chapter Outline
Chapter 1: Defines the Winged IV Needles study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Related Reports
The global market for Winged IV Needles was valued at US$ 1564 million in the year 2024 and is projected to reach a revised size of US$ 2130 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published: 2025-07-27
Pages: 96
USD 2900.00
(Single User License)
The global Winged IV Needles market size was US$ 1564 million in 2024 and is forecast to a readjusted size of US$ 2130 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-07-27
Pages: 94
USD 4250.00
(Single User License)
The global Winged IV Needles market is projected to grow from US$ 1564 million in 2024 to US$ 2130 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-27
Pages: 154
USD 4900.00
(Single User License)
The global market for Winged IV Needles was estimated to be worth US$ 1564 million in 2024 and is forecast to a readjusted size of US$ 2130 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-07-27
Pages: 127
USD 3950.00
(Single User License)
The global market for Winged IV Needles was estimated to be worth US$ 1626 million in 2025 and is projected to reach US$ 2218 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 111
USD 3950.00
(Single User License)
The global Winged IV Needles market was valued at US$ 1626 million in 2025 and is anticipated to reach US$ 2218 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 126
USD 2900.00
(Single User License)
The global Winged IV Needles market size was US$ 1626 million in 2025 and is forecast to reach a readjusted size of US$ 2218 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 95
USD 4250.00
(Single User License)
The global market for Winged IV Needles was valued at US$ 1564 million in the year 2024 and is projected to reach a revised size of US$ 2130 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Published: 2025-07-27
Pages: 96
The global Winged IV Needles market size was US$ 1564 million in 2024 and is forecast to a readjusted size of US$ 2130 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-07-27
Pages: 94
The global Winged IV Needles market is projected to grow from US$ 1564 million in 2024 to US$ 2130 million by 2031, at a CAGR of 4.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-27
Pages: 154
The global market for Winged IV Needles was estimated to be worth US$ 1564 million in 2024 and is forecast to a readjusted size of US$ 2130 million by 2031 with a CAGR of 4.6% during the forecast period 2025-2031.
Published: 2025-07-27
Pages: 127
The global market for Winged IV Needles was estimated to be worth US$ 1626 million in 2025 and is projected to reach US$ 2218 million, growing at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-09
Pages: 111
The global Winged IV Needles market was valued at US$ 1626 million in 2025 and is anticipated to reach US$ 2218 million by 2032, at a CAGR of 4.6% from 2026 to 2032.
Published: 2026-03-12
Pages: 126
The global Winged IV Needles market size was US$ 1626 million in 2025 and is forecast to reach a readjusted size of US$ 2218 million by 2032 with a CAGR of 4.6% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 95
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database